<i>BRAF</i> V600E is associated with higher incidence of second cancers in adults with Langerhans cell histiocytosis

Abstract

In this retrospective study, BRAF mutation status did not correlate with disease extent or (event-free) survival in 156 adults with Langerhans cell histiocytosis. BRAFV600E was associated with an increased incidence of second malignancies, often comprising hematological cancers, which may be clonally related.